ReviewPharmaceuticals (Basel, Switzerland)2026
Translational Development of Oral FXIa Inhibitors: A Systematic Review of Molecular Design, Pharmacology, and Indication-Specific Clinical Evidence.
Michał Janiak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.